WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005009433) USE OF 3,5 DIIODOTHYRONINE AS REGULATORS OF LIPID METABOLISM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/009433    International Application No.:    PCT/IT2004/000402
Publication Date: 03.02.2005 International Filing Date: 22.07.2004
IPC:
A61K 31/198 (2006.01)
Applicants: GOGLIA, Fernando [IT/IT]; (IT).
LANNI, Antonia [IT/IT]; (IT) (For US Only).
LOMBARDI, Assunta [IT/IT]; (IT) (For US Only).
MORENO, Maria [IT/IT]; (IT) (For US Only)
Inventors: GOGLIA, Fernando; (IT).
LANNI, Antonia; (IT).
LOMBARDI, Assunta; (IT).
MORENO, Maria; (IT)
Agent: CIRILLO, Gennaro; Brevetti Ing. Cirillo G. & C. S.A.S, Via Santa Lucia N 15, I-80132 Napoli (IT)
Priority Data:
RM 2003 A 000363 24.07.2003 IT
Title (EN) USE OF 3,5 DIIODOTHYRONINE AS REGULATORS OF LIPID METABOLISM
(FR) UTILISATION DE LA 3,5 DIIODOTHYRONINE EN TANT QUE REGULATEUR DU METABOLISME LIPIDIQUE
Abstract: front page image
(EN)It has been described a composition including 3,5_T2 in terapeutically efficient doses and diluents and/or vehicles and/or additives pharmaceutically acceptable, to be utilized in all the pre-pathologic and pathologic states related to overweight, and/or obesity, and/or hepatic steatosis alcholic and non-alcholic, and/or dislipidemies, including hypercholesterolemies and hypertryglyceridemies, and/or presence of atherosclerotic plaques and/or hepatopaties associated to dismetabolism, and/or correction of altered lipid metabolism in diabetic subjects, and/or colecistopaties, and/or deposition of undercutaneous fat, including cellulite, and/or vaso motoric rinite, including the allergic one.
(FR)L'invention concerne une composition comprenant de la 3,5_T2 en doses efficaces au plan thérapeutique et des diluants et/ou des véhicules et/ou des additifs acceptables au plan pharmaceutique, à utiliser dans tous les états pré-pathologiques et pathologiques relatifs au surpoids, et/ou à l'obésité, et/ou à la stéatose hépatique alcoolique ou non-alcoolique, et/ou aux dyslipidémies, dont les hypercholestérolémies et les hypertriglycéridémies, et/ou à la présence de plaques athérosclérotiques et/ou aux hépatopathies associées au dysmétabolisme chez des sujets diabétiques, et/ou aux cholécystopathies, et/ou au dépôt de graisse sous-cutanée, dont la cellulite, et/ou à la rhinite vasomotrice, dont la rhinite allergique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)